Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013
GlobalData's clinical trial report, Nonmelanomatous Sk...
clinical Trials By Trial Status 17
unaccomplished Trials Of Nonmelanomatous Skin Cancer 18
subjects Recruited Over A Perio...
case Comprehensive Cancer Center 41
clinical Trial Overview Of Case Comprehensive Cancer Center 41
oregon Health And Scien...
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
N...
Upcoming SlideShare
Loading in …5
×

Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013:Industry Trends, Size and Shares Research Report

116
-1

Published on

Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013
@ http://www.researchmoz.us/nonmelanomatous-skin-cancer-global-clinical-trials-review-h2-2013-report.html

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
116
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013:Industry Trends, Size and Shares Research Report

  1. 1. Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013 GlobalData's clinical trial report, Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013" provides data on the Nonmelanomatous Skin Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonmelanomatous Skin Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonmelanomatous Skin Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy Understand the dynamics of a particular indication in a condensed manner Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 nonmelanomatous Skin Cancer 6 report Guidance 6 clinical Trials By Region 7 clinical Trials By Country 8 top Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 clinical Trials By G7 Nations 13 clinical Trials In G7 Nations By Trial Status 14 clinical Trials By Phase 15 in Progress Trials By Phase 16 Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013
  2. 2. clinical Trials By Trial Status 17 unaccomplished Trials Of Nonmelanomatous Skin Cancer 18 subjects Recruited Over A Period Of Time 20 prominent Sponsors 21 top Companies Participating In Nonmelanomatous Skin Cancer Therapeutics Clinical Trials 22 prominent Drug Comparison 23 clinical Trial Profiles 24 clinical Trial Overview Of Top Companies 24 zbc Multicare 24 clinical Trial Overview Of Zbc Multicare 24 pharmaqest Pty. Ltd. 25 clinical Trial Overview Of Pharmaqest Pty. Ltd. 25 genextra S.p.a. 26 clinical Trial Overview Of Genextra S.p.a. 26 healthpoint Biotherapeutics 27 clinical Trial Overview Of Healthpoint Biotherapeutics 27 pfizer Inc. 28 clinical Trial Overview Of Pfizer Inc. 28 galderma S.a. 29 clinical Trial Overview Of Galderma S.a. 29 clinical Trial Overview Of Top Institutes / Government 30 national Cancer Institute 30 clinical Trial Overview Of National Cancer Institute 30 roswell Park Cancer Institute 31 clinical Trial Overview Of Roswell Park Cancer Institute 31 the University Of Arizona 32 clinical Trial Overview Of The University Of Arizona 32 the University Of Sydney 33 clinical Trial Overview Of The University Of Sydney 33 the University Of Chicago 34 clinical Trial Overview Of The University Of Chicago 34 the Cleveland Clinic 35 clinical Trial Overview Of The Cleveland Clinic 35 baylor College Of Medicine 36 clinical Trial Overview Of Baylor College Of Medicine 36 north Central Cancer Treatment Group 37 clinical Trial Overview Of North Central Cancer Treatment Group 37 the Medical University Of Graz 38 clinical Trial Overview Of The Medical University Of Graz 38 northwestern University 39 clinical Trial Overview Of Northwestern University 39 university Of Massachusetts 40 clinical Trial Overview Of University Of Massachusetts 40 Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013
  3. 3. case Comprehensive Cancer Center 41 clinical Trial Overview Of Case Comprehensive Cancer Center 41 oregon Health And Science University 42 clinical Trial Overview Of Oregon Health And Science University 42 rigshospitalet 43 clinical Trial Overview Of Rigshospitalet 43 university Of California, San Diego 44 clinical Trial Overview Of University Of California, San Diego 44 massachusetts General Hospital 45 clinical Trial Overview Of Massachusetts General Hospital 45 national Institute Of Arthritis And Musculoskeletal And Skin Diseases 46 clinical Trial Overview Of National Institute Of Arthritis And Musculoskeletal And Skin Diseases 46 university Of Alabama At Birmingham 47 clinical Trial Overview Of University Of Alabama At Birmingham 47 university Of Wisconsin Madison 48 clinical Trial Overview Of University Of Wisconsin Madison 48 university Of California, Irvine 49 clinical Trial Overview Of University Of California, Irvine 49 five Key Clinical Profiles 50 appendix 69 abbreviations 69 definitions 69 research Methodology 70 secondary Research 70 about Globaldata 71 contact Us 71 disclaimer 71 source 72 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013
  4. 4. Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013

×